Characterization of Pasteurella multocida isolates recovered from the oral flora of cats

Abstract

In this study, it was aimed to investigate the presence of Pasteurella multocida in the swab samples taken from the oral cavity of cats, and to determine the capsular type and antimicrobial susceptibility of the isolates. For this purpose, swab samples taken from 300 cats were inoculated onto Knight's selective enriched medium and blood agar for isolation of P. multocida. Following

after capsular typing of the isolates by PCR, the susceptibilities of the isolates to ceftiofur, clindamycin, erythromycin, enrofloxacin, amoxicillin+clavulanic acid, trimethoprim/ sulfamethoxazole, tetracycline, and chloramphenicol were examined by the disk diffusion method. The relationships between oral colonization and various physiological and behavioral variables were evaluated, statistically. P. multocida was isolated from 48 (16%) of the samples and all strains were typed as capsular type A. While all of the isolates were resistant to clindamycin and susceptible to enrofloxacin, 8,33% tetracycline resistance was also remarkable. Multiple antibiotic resistance (MDR) was detected in 27% of the isolates. The colonization of P. multocida was found to be statistically significant in cats under the age of 1 and in cats living outdoors. The importance of antibiotic resistance observed in bacteria with a zoonotic character such as P. multocida should not be ignored since it poses a threat to public health. It was concluded that, in this study determination of tetracycline resistance, which has started to be reported in feline Pasterurella multocida isolates in recent years, and detection of multiple antibiotic resistance in 27% of isolates, was extremely important for public health.

Keywords

• Antimicrobial susceptibility
• Capsular typing
• Cat
• Oral swab
• Pasteurella multocida

References

1. 1. Adler CJ, Malik R, Browne G V, et al (2016): Diet may influence the oral microbiome composition in cats. Microbiome, 4, 23.
2. 2. Arumugam ND, Ajam N, Blackall PJ, et al (2011): Capsular serotyping of Pasteurella multocida from various animal hosts-a comparison of phenotypic and genotypic methods. Trop Biomed, 28, 55–63.
3. 3. Björkholm B, Eilard T (1983): Pasteurella multocida osteomyelitis caused by cat. bite J Infect, 6, 175–177.
4. 4. Bourély C, Cazeau G, Jouy E, et al (2019): Antimicrobial resistance of Pasteurella multocida isolated from diseased food-producing animals and pets. Vet Microbiol, 235, 280–284.
5. 5. Boyce JD, Chung JY, Adler B (2000): Pasteurella multocida capsule: Composition, function and genetics. J Biotechnol, 83, 153–160.
6. 6. Chen Y, Sun E, Song J, et al (2018): Complete Genome Sequence of a Novel T7-Like Bacteriophage from a Pasteurella multocida Capsular Type A Isolate. Curr Microbiol, 75, 574–579.
7. 7. CLSI (2018): Performance standarts for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; Informational Supplement. 4th ed. CLSI supplement VET08.
8. 8. Dolieslager SMJ, Riggio MP, Lennon A, et al (2011): Identification of bacteria associated with feline chronic gingivostomatitis using culture-dependent and culture-independent methods. Vet Microbiol, 148, 93–98.

9. 9. Donnio PY, Lerestif-Gautier AL, Avril JL (2004): Characterization of Pasteurella spp. strains isolated from human infections. J Comp Pathol, 130, 137–142.
10. 10. Fernandez-Esparrach G, Mascaro J, Rota R, et al (1994): Septicemia, peritonitis, and empyema due to Pasteurella multocida in a cirrhotic patient. Clin Infect Dis, 18, 486.
11. 11. Ferreira TS, Moreno LZ, Felizardo MR, et al (2016): Pheno- and genotypic characterization of Pasteurella multocida isolated from cats, dogs and rabbits from Brazil. Comp Immunol Microbiol Infect Dis, 45, 48–52.
12. 12. Freshwater A (2008): Why your housecat’s trite little bite could cause you quite a fright: a study of domestic felines on the occurrence and antibiotic susceptibility of Pasteurella multocida. Zoonoses Public Heal, 55, 507–513.
13. 13. Ganiere JP, Escande F, Andre G, et al (1993): Characterization of Pasteurella from gingival scrapings of dogs and cats. Comp Immunol Microbiol Infect Dis, 16, 77–85.
14. 14. Hatfaludi T, Al-Hasani K, Boyce JDJD, et al (2010): Outer membrane proteins of Pasteurella multocida. Vet Microbiol, 144, 1–17.
15. 15. Ivana S, Câmpeanu G, Bogdan AT, et al (2010): Characterization of Pasteurella sp. strains by macrorestriction profiles of PFGE bands from oral swab samples. Rom Biotechnol Lett, 15, 5034–5041.
16. 16. Kawamoto E, Sawada T, Maruyama T (1997): Evaluation of transport media for Pasteurella multocida isolates from rabbit nasal specimens. J Clin Microbiol, 35, 1948–1951.
17. 17. Kimura R, Hayashi Y, Takeuchi T, et al (2004): Pasteurella multocida septicemia caused by close contact with a domestic cat: Case report and literature review. J Infect Chemother, 10, 250–252.
18. 18. Knight DP, Paine JE, Speller DC (1983): A selective medium for Pasteurella multocida and its use with animal and human specimens. J Clin Pathol, 36, 591–594.
19. 19. Kouppari G, Garoufi A, Stamos G, et al (1999): Pasturella multocida septicemia and meningitis in an infant. Clin Microbiol Infect, 5, 101–102.
20. 20. Magiorakos A, Srinivasan A, Carey RB, et al (2012): Multidrug‐resistant, extensively drug‐resistant and pandrug‐resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect, 18, 268–281.
21. 21. Masuoka H, Shimada K, Kiyosue-Yasuda T, et al (2017): Transition of the intestinal microbiota of cats with age. PLoS One, 12, 1-9.
22. 22. Mohan K, Kelly PJ, Hill FWG, et al (1997): Phenotype and serotype of Pasteurella multocida isolates from diseases of dogs and cats in Zimbabwe. Comp Immunol Microbiol Infect Dis, 20, 29–34.
23. 23. Morrissey I, Moyaert H, de Jong A, et al (2016): Antimicrobial susceptibility monitoring of bacterial pathogens isolated from respiratory tract infections in dogs and cats across Europe: ComPath results. Vet Microbiol, 191, 44–51.
24. 24. Moyaert H, de Jong A, Simjee S, et al (2019): Survey of antimicrobial susceptibility of bacterial pathogens isolated from dogs and cats with respiratory tract infections in Europe: ComPath results. J Appl Microbiol, 127, 29–46.
25. 25. Moyaert H, de Jong A, Simjee S, et al (2014): Antimicrobial resistance monitoring projects for zoonotic and indicator bacteria of animal origin: common aspects and differences between EASSA and EFSA. Vet Microbiol, 171, 279–283.
26. 26. Nakanishi H, Furuya M, Soma T, et al (2019): Prevalence of microorganisms associated with feline gingivostomatitis. J Feline Med Surg, 21, 103–108.
27. 27. NCCLS (2004): Performance Standarts for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Informational Supplement. NCCLS document M31-S1.
28. 28. Orsini J, Perez R, Llosa A, et al (2013): Non-zoonotic Pasteurella multocida infection as a cause of septic shock in a patient with liver cirrhosis: a case report and review of the literature. J Glob Infect Dis, 5, 176.
29. 29. Tamaskar I, Ravakhah K (2004): Spontaneous bacterial peritonitis with Pasteurella multocida in cirrhosis: case report and review of literature. South Med J, 97, 1113–1115.
30. 30. Tefera G, Smola J (2002): Modification of Cary-Blair Transport Medium for Pasteurella multocida and Mannheimia haemolytica. Acta Vet Brno, 71, 229–233.
31. 31. The European Committee on Antimicrobial Susceptibility Testing. (2017): Breakpoint tables for interpretation of MICs and zone diameters. Version 7.0. http://www.eucast.org. (Accessed March 12,2020).
32. 32. Townsend KM, Boyce JD, Chung JY, et al. (2001): Genetic organization of Pasteurella multocida cap loci and development of a multiplex capsular PCR typing system. J Clin Microbiol, 39, 924-929.
33. 33. Townsend KM, Frost AJ, Lee CW, et al. (1998): Development of PCR assays for species-and type-specific identification of Pasteurella multocidaisolates. J Clin Microbiol, 36, 1096–1100.
34. 34. Ujvári B, Weiczner R, Deim Z, et al. (2019): Characterization of Pasteurella multocida strains isolated from human infections. Comp Immunol Microbiol Infect Dis, 63, 37–43.